| Adherence to long-term therapies: evidence for action World Health Organization World Health Organization, 2003 | 6132 | 2003 |
| Adherence to long-term therapies: evidence for action E Sabaté World Health Organization, 2003 | 5510 | 2003 |
| Adherence to long-term therapies: evidence for action S De Geest, E Sabaté European Journal of Cardiovascular Nursing 2 (4), 323-323, 2003 | 640 | 2003 |
| Adherence to long-term therapies: evidence for action PV Burkhart, E Sabaté Journal of nursing scholarship: an official publication of Sigma Theta Tau …, 2003 | 452 | 2003 |
| WHO adherence meeting report E Sabate Geneva: World Health Organization, 2001 | 197 | 2001 |
| Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 … D Stark, M Nankivell, E Pujade-Lauraine, G Kristensen, L Elit, M Stockler, ... The lancet oncology 14 (3), 236-243, 2013 | 182 | 2013 |
| The challenge of chronic conditions: WHO responds: the sooner governments act, the better JA Epping-Jordan, R Bengoa, R Kawar, E Sabaté Bmj 323 (7319), 947-948, 2001 | 162 | 2001 |
| Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003 E Sabate NLM classification: W 85, 2016 | 139 | 2016 |
| Adherence to long-term therapies: policy for action: meeting report, 4-5 June 2001 E Sabaté, World Health Organization World Health Organization, 2001 | 80 | 2001 |
| Adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization; 2003 E Sabaté WHO/MNC/03.01, 2018 | 64 | 2018 |
| Adherence to long-term therapies: evidence for action: World Health Organization E Sabaté, E Sabaté Retreived from: http://whqlibdoc. who. int/publications/2003/9241545992. pdf, 2003 | 55 | 2003 |
| Adherencia a los tratamientos a largo plazo E Sabaté Génova: organización Mundial de la Salud, 2004 | 44 | 2004 |
| World bank pharmaceuticals R Govindaraj, MR Reich, JC Cohen World Bank, Washington, DC, 2000 | 40 | 2000 |
| Adherence to long-term therapies management: a call for cardiovascular nursing managers and policymakers E Sabaté, S De Geest Progress in cardiovascular nursing 19 (1), 28-29, 2004 | 22 | 2004 |
| Depression in young people and the elderly E Sabaté Priority medicines for Europe and the world “A public health approach to …, 2004 | 21 | 2004 |
| Adherence to heroin dependence therapies and human immunodeficiency virus/acquired immunodeficiency syndrome infection rates among drug abusers S De Castro, E Sabaté Clinical infectious diseases 37 (Supplement_5), S464-S467, 2003 | 18 | 2003 |
| Adherencia a los tratamientos a largo plazo: pruebas para la acción World Health Organization Organización Mundial de la Salud, 2004 | 13 | 2004 |
| The magnitude of the problem of poor adherence World Health Organization Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland …, 2003 | 13 | 2003 |
| Organización Mundial de la Salud E Sabaté Adherencia a los tratamientos a largo plazo: pruebas para la acción …, 2004 | 9 | 2004 |
| Guidelines for epidemiological reviews: the Global Burden of Disease 2000 project CD Mathers, E Sabaté, AD Lopez Global Programme on Evidence for Health Policy World Health Organization, 2001 | 6 | 2001 |
Michael R. ReichProfessor of International Health Policy, Harvard School of Public HealthDirección de correo verificada de harvard.edu
